Hot Features
Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of so... Endonovo Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and distribution of non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardio chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular, and peripheral artery disease (PAD) and ischemic stroke. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 600579 | 8.617E-5 | CS |
| 4 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 400355 | 9.111E-5 | CS |
| 12 | 9.9E-5 | 9900 | 1.0E-6 | 0.0001 | 1.0E-6 | 1427643 | 9.81E-5 | CS |
| 26 | 0 | 0 | 0.0001 | 0.0001 | 1.0E-6 | 1583837 | 8.784E-5 | CS |
| 52 | -0.0001 | -50 | 0.0002 | 0.0003 | 1.0E-6 | 7140022 | 0.00010633 | CS |
| 156 | -0.01465 | -99.3220338983 | 0.01475 | 0.0168 | 1.0E-6 | 6818678 | 0.00039914 | CS |
| 260 | -0.0442 | -99.7742663657 | 0.0443 | 0.06 | 1.0E-6 | 3985769 | 0.00088856 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.